DIDHZFPOZUQPPA-UHFFFAOYSA-N CC (C (CSC (C (CS) NC (C)= O)= O) NC (C)= O)= O
Chemical compound CC (C (CSC (C (CS) NC (C)= O)= O) NC (C)= O)= O …

EP2755645A1 - Pharmaceutical combinations including anti-inflammatory and antioxidant
conjugates useful for treating metabolic disorders - Google Patents EP2755645A1 …

The present disclosure relates to sugar-linker-drug conju gates, of the formula JA-B-] nLD,
wherein A is a saccha ride; B is a spacer, n is an integer selected from 1 to 3; L is a linker …

0003 2. Related Art 0004) Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the
most commonly prescribed groups of drugs Worldwide and are highly effective as analgesic …

2013-07-01 Assigned to GENMEDICA THERAPEUTICS SL reassignment GENMEDICA
THERAPEUTICS SL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …

2010-05-13 Assigned to GENMEDICA THERAPEUTICS SL reassignment GENMEDICA
THERAPEUTICS SL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …

RHIUAMDTBZSYOZ-UHFFFAOYSA-N CC (C)(C) SC1= NC= C ([N+](= O)[O-]) C= C1
Chemical compound CC (C)(C) SC1= NC= C ([N+](= O)[O-]) C= C1 RHIUAMDTBZSYOZ …

A61K47/50—Medicinal preparations characterised by the non-active ingredients used, eg
carriers or inert additives; Targeting or modifying agents chemically bound to the active …

(57) ABSTRACT A therapeutic composition includes a salicylate administer ing concert with
at least one salicylate excretion compound of a glycine salicylate conjugate and a …

The invention relates to fatty acid niacin conjugates; com positions comprising an effective
amount of a fatty acid niacin conjugate; and methods for treating or preventing an metabolic …